A consensus report of the Diabetes in Pregnancy Study Group of North America Conference, Little Rock, Arkansas, May 2002.
Reece
E A
EA
The Department of Obstetrics, University of Arkansas College of Medicine, Little Rock, Arkansas 72205, USA.
Homko
C
C
Miodovnik
M
M
Langer
O
O
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D015190:Blood Glucose Self-Monitoring; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D003920:Diabetes Mellitus / Q000503:physiopathology*; D016640:Diabetes, Gestational / Q000188:drug therapy* / Q000503:physiopathology; D003928:Diabetic Nephropathies / Q000188:drug therapy; D005314:Embryonic and Fetal Development / Q000502:physiology*; D005260:Female; D005320:Fetal Macrosomia / Q000503:physiopathology; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D011247:Pregnancy; D011256:Pregnancy Outcome; D011254:Pregnancy in Diabetics / Q000188:drug therapy* / Q000503:physiopathology; D011296:Prenatal Diagnosis
D000806:Angiotensin-Converting Enzyme Inhibitors; D002121:Calcium Channel Blockers; D007004:Hypoglycemic Agents